Randomized comparative clinical study on alpha 1 receptor blockers silodosin and urapidil for female lower urinary tract symptoms

Trial Profile

Randomized comparative clinical study on alpha 1 receptor blockers silodosin and urapidil for female lower urinary tract symptoms

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Silodosin (Primary) ; Urapidil (Primary)
  • Indications Urinary tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Sep 2016 Interim results assessing safety and efficacy of silodosin and urapidil in patients with lower urinary tract infections (n=49) presented at the 46th Annual Meeting of the International Continence Society.
    • 18 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top